Company – Scrape Financial
Risk Factors Summary

Risk Factors Update Summary

  • The company faces substantial doubt about its ability to continue due to an accumulated deficit of $167,761,883 and negative cash flows of $13,189,390 in 2023.
  • Potential dilution risk due to future equity offerings with 1,806,589 warrants outstanding at $21.52/share.
  • The company may need to raise significant additional capital to meet short-term obligations of $3,951,031, including a short-term note payable of $150,408.
  • Stock price volatility could lead to loss of investment; impacted by market conditions and litigation.
  • The use of AI in the company's business poses risks due to evolving technologies, potential flaws in algorithms, and regulatory changes.
  • Ownership changes may limit loss carryforwards; impact from future common stock issuances.
  • The company's collaborations and partnerships may not lead to commercially viable products or generate significant revenues, impacting future operations.
  • Limited ability to provide stock-based incentives due to low shares available for issuance.
  • The company may face challenges in sourcing materials for molecular diagnostic tests, potentially leading to interruptions in test processing.
  • The company's R&D efforts for the PEDAL platform may face delays, impacting commercial revenues and development timelines.
  • The company's ability to scale operations to meet growing demand for molecular diagnostic tests may impact test quality and result in product liability claims.

Full Text Changes in Most Recent 10-K

Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.

To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1446159&owner=exclude

Click here to download the PDF

This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.